THURMAN RANDY H

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 218%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
THURMAN RANDY H's trades of Outlook Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
43.85
Quantity 47,480 +45.1%
Value US$1,236,281
Transaction date
Purchase
Price
275.24
Quantity 36,915 -30.3%
Value US$2,924,962
Transaction date
Sale
Price
221.33
Quantity 84,230 -43.9%
Value US$3,669,137
Transaction date
Purchase
Price
19.94
Quantity 3,000 +42.9%
Value US$59,820
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-26
B Purchase
47,480 +45.1%
43.85
US$1,236,281 		47,480 +45.1% 43.85 US$1,236,281
2021-05-19 2021-05-18
B Purchase
36,915 -30.3%
275.24
US$2,924,962 		36,915 -30.3% 275.24 US$2,924,962
2020-11-13 2020-11-13
S Sale
84,230 -43.9%
221.33
US$3,669,137 		84,230 -43.9% 221.33 US$3,669,137
2020-11-13 2020-11-11
S Sale
34,504 -87.3%
15.91
US$548,890 		34,504 -87.3% 15.91 US$548,890
2020-09-15 2020-09-14
B Purchase
10,000 +533.3%
0.62
US$6,200 		10,000 +533.3% 0.62 US$6,200
2019-10-29 2019-10-25
B Purchase
5,000 +inf%
5.00
US$25,000 		5,000 +inf% 5.00 US$25,000
2004-05-11 2004-05-11
B Purchase
3,000 +42.9%
19.94
US$59,820 		3,000 +42.9% 19.94 US$59,820